The American Dental Association has adopted a policy supporting certain statutory limits on opioid dosage and duration and mandatory continuing education in prescribing opioids and other controlled substances. The policy also supports dentists using prescription drug monitoring programs and improving state PDMPs to make them more interoperable. “As president of the ADA, I call upon dentists everywhere to double down on their efforts to prevent opioids from harming our patients and their families,” said ADA President Joseph Crowley. “This new policy demonstrates ADA’s firm commitment to help fight the country’s opioid epidemic while continuing to help patients manage dental pain.” 

Related News Articles

Headline
To encourage drug companies to seek approval for over-the-counter versions of naloxone, an emergency treatment for opioid overdose, the Food and Drug…
Headline
Patients in the most rural counties had an 87 percent greater chance of receiving an opioid prescription from their primary care provider between January 2014…
Headline
Continued rising drug prices, as well as shortages for many critical medications, are disrupting patient care and forcing hospitals to delay infrastructure and…
Headline
U.S. overdose death rates linked to synthetic opioids increased more than 45 percent in 2017, likely driven by illicitly manufactured fentanyl, according to a…
Headline
The Health Resources and Services Administration recently launched a program to provide eligible health care clinicians with student loan repayment assistance…
Insights and Analysis
Also in this weekly roundup of health care news: how mandated access to at-home palliative care has made all the difference for some patients; and a town’s…